These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dose-effect relationships in neuroendocrine tumour liver metastases treated with [ Ramdhani K; Beijer-Verduin J; Ebbers SC; van Rooij R; Smits MLJ; Bruijnen RCG; de Jong HWAM; Lam MGEH; Braat AJAT Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2114-2123. PubMed ID: 38369678 [TBL] [Abstract][Full Text] [Related]
5. First Evidence for a Dose-Response Relationship in Patients Treated with Bastiaannet R; van Roekel C; Smits MLJ; Elias SG; van Amsterdam WAC; Doan D; Prince JF; Bruijnen RCG; de Jong HWAM; Lam MGEH J Nucl Med; 2020 Apr; 61(4):608-612. PubMed ID: 31601696 [No Abstract] [Full Text] [Related]
6. Additional hepatic Braat AJAT; Kwekkeboom DJ; Kam BLR; Teunissen JJM; de Herder WW; Dreijerink KMA; van Rooij R; Krijger GC; de Jong HWAM; van den Bosch MAAJ; Lam MGEH BMC Gastroenterol; 2018 Jun; 18(1):84. PubMed ID: 29902988 [TBL] [Abstract][Full Text] [Related]
7. In vivo dosimetry based on SPECT and MR imaging of 166Ho-microspheres for treatment of liver malignancies. Smits ML; Elschot M; van den Bosch MA; van de Maat GH; van het Schip AD; Zonnenberg BA; Seevinck PR; Verkooijen HM; Bakker CJ; de Jong HW; Lam MG; Nijsen JF J Nucl Med; 2013 Dec; 54(12):2093-100. PubMed ID: 24136931 [TBL] [Abstract][Full Text] [Related]
8. Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study. Braat AJAT; Bruijnen RCG; van Rooij R; Braat MNGJA; Wessels FJ; van Leeuwaarde RS; van Treijen MJC; de Herder WW; Hofland J; Tesselaar MET; de Jong HWAM; Lam MGEH Lancet Oncol; 2020 Apr; 21(4):561-570. PubMed ID: 32112737 [TBL] [Abstract][Full Text] [Related]
9. Holmium-166 Radioembolization in Hepatocellular Carcinoma: Feasibility and Safety of a New Treatment Option in Clinical Practice. Radosa CG; Radosa JC; Grosche-Schlee S; Zöphel K; Plodeck V; Kühn JP; Kotzerke J; Hoffmann RT Cardiovasc Intervent Radiol; 2019 Mar; 42(3):405-412. PubMed ID: 30603976 [TBL] [Abstract][Full Text] [Related]
10. Dose-Effect Relationships of van Roekel C; Bastiaannet R; Smits MLJ; Bruijnen RC; Braat AJAT; de Jong HWAM; Elias SG; Lam MGEH J Nucl Med; 2021 Feb; 62(2):272-279. PubMed ID: 32591491 [TBL] [Abstract][Full Text] [Related]
12. (⁹⁹m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with ¹⁶⁶Ho-microspheres. Elschot M; Nijsen JF; Lam MG; Smits ML; Prince JF; Viergever MA; van den Bosch MA; Zonnenberg BA; de Jong HW Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1965-75. PubMed ID: 24819055 [TBL] [Abstract][Full Text] [Related]
13. Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres. Shady W; Sotirchos VS; Do RK; Pandit-Taskar N; Carrasquillo JA; Gonen M; Sofocleous CT AJR Am J Roentgenol; 2016 Sep; 207(3):661-70. PubMed ID: 27384594 [TBL] [Abstract][Full Text] [Related]
14. Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial. Smits ML; Nijsen JF; van den Bosch MA; Lam MG; Vente MA; Huijbregts JE; van het Schip AD; Elschot M; Bult W; de Jong HW; Meulenhoff PC; Zonnenberg BA J Exp Clin Cancer Res; 2010 Jun; 29(1):70. PubMed ID: 20550679 [TBL] [Abstract][Full Text] [Related]
15. 90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study. Hickey R; Lewandowski RJ; Prudhomme T; Ehrenwald E; Baigorri B; Critchfield J; Kallini J; Gabr A; Gorodetski B; Geschwind JF; Abbott A; Shridhar R; White SB; Rilling WS; Boyer B; Kauffman S; Kwan S; Padia SA; Gates VL; Mulcahy M; Kircher S; Nimeiri H; Benson AB; Salem R J Nucl Med; 2016 May; 57(5):665-71. PubMed ID: 26635340 [TBL] [Abstract][Full Text] [Related]
16. Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres. Prince JF; van Rooij R; Bol GH; de Jong HW; van den Bosch MA; Lam MG J Nucl Med; 2015 Jun; 56(6):817-23. PubMed ID: 25931477 [TBL] [Abstract][Full Text] [Related]
17. 90Y Radioembolization after radiation exposure from peptide receptor radionuclide therapy. Ezziddin S; Meyer C; Kahancova S; Haslerud T; Willinek W; Wilhelm K; Biersack HJ; Ahmadzadehfar H J Nucl Med; 2012 Nov; 53(11):1663-9. PubMed ID: 22988059 [TBL] [Abstract][Full Text] [Related]